Injection of nanoparticle has proven effective in mouse models, researchers say
Researchers at Tel Aviv University have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer. Their innovative approach has so far proven effective in preventing the development of melanoma in mouse models and in treating primary tumors and metastases that result from melanoma.
The focus of the research is on a nanoparticle that serves as the basis for the new vaccine. The study was led by Prof. Ronit Satchi-Fainaro, chair of the Department of Physiology and Pharmacology and head of the Laboratory for Cancer Research and Nanomedicine at TAU’s Sackler Faculty of Medicine, and Prof. Helena Florindo of the University of Lisbon while on sabbatical at the Satchi-Fainaro lab at TAU; it was conducted by Dr. Anna Scomparin of Prof. Satchi-Fainaro’s TAU lab and postdoctoral fellow Dr. João Conniot. The results were published on August 5 in Nature Nanotechnology.
Melanoma develops in the skin cells that produce melanin or skin pigment. “The war against cancer in general, and melanoma in particular, has advanced over the years through a variety of treatment modalities, such as chemotherapy, radiation therapy and immunotherapy; but the vaccine approach, which has proven so effective against various viral diseases, has not materialized yet against cancer,” says Prof. Satchi-Fainaro. “In our study, we have shown for the first time that it is possible to produce an effective nano-vaccine against melanoma and to sensitize the immune system to immunotherapies.”
The researchers harnessed tiny particles, about 170 nanometers in size, made of a biodegradable polymer. Within each particle, they “packed” two peptides — short chains of amino acids, which are expressed in melanoma cells. They then injected the nanoparticles (or “nano-vaccines”) into a mouse model bearing melanoma.
“The nanoparticles acted just like known vaccines for viral-borne diseases,” Prof. Satchi-Fainaro explains. “They stimulated the immune system of the mice, and the immune cells learned to identify and attack cells containing the two peptides — that is, the melanoma cells. This meant that, from now on, the immune system of the immunized mice will attack melanoma cells if and when they appear in the body.”
The researchers then examined the effectiveness of the vaccine under three different conditions.
First, the vaccine proved to have prophylactic effects. The vaccine was injected into healthy mice, and an injection of melanoma cells followed. “The result was that the mice did not get sick, meaning that the vaccine prevented the disease,” says Prof. Satchi-Fainaro.
Second, the nanoparticle was used to treat a primary tumor: A combination of the innovative vaccine and immunotherapy treatments was tested on melanoma model mice. The synergistic treatment significantly delayed the progression of the disease and greatly extended the lives of all treated mice.
Finally, the researchers validated their approach on tissues taken from patients with melanoma brain metastases. This suggested that the nano-vaccine can be used to treat brain metastases as well. Mouse models with late-stage melanoma brain metastases had already been established following excision of the primary melanoma lesion, mimicking the clinical setting. Research on image-guided surgery of primary melanoma using smart probes was published last year by Prof. Satchi-Fainaro’s lab.
“Our research opens the door to a completely new approach — the vaccine approach — for effective treatment of melanoma, even in the most advanced stages of the disease,” concludes Prof. Satchi-Fainaro. “We believe that our platform may also be suitable for other types of cancer and that our work is a solid foundation for the development of other cancer nano-vaccines.”
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Bend is a ‘perfect storm’ for melanomaon August 16, 2019 at 12:01 am
For more details on how to check your skin or how to get involved in the War on Melanoma campaign, visit startseeingmelanoma.com Wearing sunscreen today? If the answer is no, maybe you should be.
- MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapyon August 15, 2019 at 1:38 pm
A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for ...
- A new treatment for advanced melanoma patients on Coast Liveon August 14, 2019 at 12:01 pm
HAMPTON ROADS, Va. - Melanoma is the most serious and life-threatening type of skin cancer. It is almost always treatable when caught early, but if it metastasizes, or spreads to other parts of ...
- Genetic test helped Utahns at risk for melanoma change behavior, study findson August 9, 2019 at 5:27 pm
SALT LAKE CITY — When people know they have a high genetic risk of melanoma, they are more likely to protect themselves from the sun, according to a new study. "For most genes that have been found for ...
- Combo Tx for Melanoma Ups CV Riskon August 9, 2019 at 11:11 am
Dual BRAF and MEK inhibition therapy for melanoma may carry certain cardiovascular harms, according to a meta-analysis. Across five randomized trials with a total of 2,317 patients, the addition of ...
- Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccineon August 6, 2019 at 3:29 am
Dissonant signaling, which can deafen the immune system to cancer, can be replaced by something more harmonious—and therapeutic—if immunotherapies silence a note, sound another, or play an especially ...
- Scientists demonstrate a new nano-vaccine preventing the spread of melanomaon August 5, 2019 at 9:41 pm
A new nano-vaccine both slowed the progression of skin cancer in mice with a primary melanoma, and prevented its initial onset in healthy mice(Credit: vitanovski/Depositphotos) A new nano-vaccine ...
- Man bikes across America to raise awareness for melanomaon August 5, 2019 at 4:23 pm
A Waukesha County man is biking across America to raise money and awareness about melanoma. He's riding for his sister Barbie. She lost her battle with melanoma last year at the age of 58.
- Skin cancer nano-vaccine protects mice from deadly melanoma cellson August 5, 2019 at 2:12 pm
Melanoma, the most deadly skin cancer, may one day be prevented and treated using a simple vaccine. Researchers with Tel Aviv University have published the results of their work with nanoparticles and ...
- Novel nano-vaccine for melanomaon August 5, 2019 at 11:53 am
Researchers have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer. Their approach has so far proven effective in preventing the development of melanoma in mouse ...
via Bing News